The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The company emphasized that its mRNA system is built on three pillars—mRNA science, delivery science, and manufacturing processes
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers
New Gurugram centre is India's first clinical Prevention Centre with 2 state of the art MRI machines and a capacity of 2000 scans a month
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
AI-powered remote patient monitoring platform earns recognition at AI in Healthcare 2.0 for advancing continuous, preventive, and personalized healthcare delivery
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
Subscribe To Our Newsletter & Stay Updated
